<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>diffuse midline glioma &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/diffuse-midline-glioma/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Wed, 26 Nov 2025 20:00:43 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>diffuse midline glioma &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>AI-Enhanced Biopsy Decisions in Diffuse Midline Glioma</title>
		<link>https://bioengineer.org/ai-enhanced-biopsy-decisions-in-diffuse-midline-glioma/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Wed, 26 Nov 2025 20:00:18 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[cryosection pathology]]></category>
		<category><![CDATA[diffuse midline glioma]]></category>
		<category><![CDATA[intraoperative AI]]></category>
		<category><![CDATA[pediatric brain tumors]]></category>
		<category><![CDATA[real-time biopsy decision]]></category>
		<guid isPermaLink="false">https://bioengineer.org/ai-enhanced-biopsy-decisions-in-diffuse-midline-glioma/</guid>

					<description><![CDATA[In the relentless pursuit of advancing neurosurgical precision, a groundbreaking study published in Nature Communications outlines how artificial intelligence (AI) is revolutionizing decision-making workflows during the biopsy of diffuse midline gliomas (DMGs), one of the most challenging brain tumors to diagnose and treat. Led by Yuan, Y., Yue, Q., and Wang, Y., among others, this [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">301851</post-id>	</item>
	</channel>
</rss>
